Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

788
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
788
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

621
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
621
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

750
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
750
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

1.8K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resolving uncertainties in patient selection for mechanical circulatory support after out-of-hospital cardiac arrest.

Resuscitation·2026
Same author

Computational modelling for personalized transcatheter aortic valve replacement planning: a systematic review of complications and decision support.

Frontiers in digital health·2026
Same author

Evaluating possible treatment effect heterogeneity in a randomized trial of milrinone versus dobutamine in cardiogenic shock.

Critical care (London, England)·2026
Same author

Invasive ventilation and association with outcomes in heart failure-related cardiogenic shock.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Efficacy of the Shear Stress Pattern Computed in Coronary Artery Reconstruction Models With and Without Side Branches in Predicting Plaque Progression.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

A randomized crossover clinical trial comparing 24-h blood pressure measurements from two different cuffless wrist ambulatory monitors with cuffed ambulatory monitoring for translation to clinical practice: Rationale and Design of Continuum BP study.

American heart journal plus : cardiology research and practice·2026
Same journal

The Finding of Posterior Wall Low-Voltage Zones During Cryoballoon Pulmonary Vein Isolation Facilitated by Periprocedural Electroanatomical Mapping Is Associated with a Worse Ablation Outcome.

Journal of cardiovascular development and disease·2026
Same journal

Autonomic Nervous Dysfunction and Ultra-Short-Term Heart Rate Variability in Atrial Fibrillation: Recent Advances in Early Detection.

Journal of cardiovascular development and disease·2026
Same journal

QRS-Corrected Prediction of the Diastolic Rest Period for Coronary CT Angiography in Patients with Complete Left Bundle Branch Block.

Journal of cardiovascular development and disease·2026
Same journal

Colchicine in Coronary Artery Disease-Too Much of a Good Thing?

Journal of cardiovascular development and disease·2026
Same journal

ANO1 (TMEM16A) Genetic Variants, Promoter Methylation, and Chloride Dysregulation in Pulmonary Hypertension.

Journal of cardiovascular development and disease·2026
Same journal

Prognostic Value of the Uric Acid-to-Albumin Ratio in Patients Undergoing Successful Percutaneous Coronary Intervention for Chronic Total Occlusion.

Journal of cardiovascular development and disease·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

2.8K

Cardiogenic Shock: Clinical Management, Outcomes and Future Directions.

Aaqil Ahmad Aubdool1, Andrew J Sullivan2,3, Daniel A Jones2,3,4

  • 1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AD, UK.

Journal of Cardiovascular Development and Disease
|April 27, 2026
PubMed
Summary
This summary is machine-generated.

Cardiogenic shock, a critical heart condition, requires urgent management. This review details current treatments, challenges, and future directions for improving patient outcomes and reducing healthcare burdens.

Keywords:
Impellacardiogenic shockcoronary artery bypass graft (CABG)extracorporeal membrane oxygenation (ECMO)intra-aortic balloon pump (IABP)percutaneous coronary intervention (PCI)

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.3K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

27.2K

Related Experiment Videos

Last Updated: Apr 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

2.8K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.3K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

27.2K

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Health Services Research

Background:

  • Cardiogenic shock is a severe complication of myocardial infarction or heart failure, leading to inadequate blood flow and potential organ failure.
  • Prompt intervention is crucial to prevent mortality and end-organ damage.

Purpose of the Study:

  • To review current management strategies for cardiogenic shock.
  • To evaluate the effectiveness of pharmacological and mechanical support therapies.
  • To explore challenges in healthcare provision and identify future research directions.

Main Methods:

  • Literature review of current treatments for cardiogenic shock.
  • Analysis of pharmacological therapies and mechanical circulatory support devices.
  • Examination of healthcare costs, resource utilization, and regional disparities.

Main Results:

  • Current treatments include medications and mechanical support, but challenges remain in optimizing their use.
  • Early detection and intervention are key to improving survival rates.
  • Significant healthcare resources are utilized, with notable regional variations.

Conclusions:

  • Effective management of cardiogenic shock requires a multifaceted approach combining timely diagnosis, appropriate therapies, and optimized resource allocation.
  • Future research should focus on novel technologies, improved trial designs, and enhanced prevention strategies to reduce morbidity and mortality.